SCHEMBL1848971

SCHEMBL1848971

FCCCCOc1ccccc1-c1cc2ccccn2c1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.65
ALDH1A1 P00352 6/20 0.41
POLB P06746 5/20 0.41
KDM4E B2RXH2 5/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 2/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.38
LMNA P02545 3/20 0.36
PDE5A O76074 1/20 0.36
HTR7 P34969 1/20 0.35
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1855460 0.92 HRH3 (0.64) HRH3ALDH1A1POLBKDM4ERAB9A
SCHEMBL13394698 0.79 HRH3 (0.66) HRH3ALDH1A1POLBKDM4ERAB9A
SCHEMBL4295616 0.79 HRH3 (1.00) HRH3ALDH1A1POLBKDM4ESMN1; SMN2
SCHEMBL6642828 0.75 HRH3 (0.60) HRH3ALDH1A1POLBKDM4ERAB9A
SCHEMBL3891998 0.75 HRH3 (0.53) HRH3ALDH1A1POLBKDM4ERAB9A
SCHEMBL29753975 0.71 ALDH1A1 (0.51) HRH3ALDH1A1POLBKDM4ERAB9A
SCHEMBL13394694 0.70 HRH3 (0.65) HRH3ALDH1A1POLBKDM4ERAB9A
SCHEMBL8091834 0.69 HRH3 (0.66) HRH3ALDH1A1POLBKDM4ERAB9A
SCHEMBL17620577 0.68 ALDH1A1 (0.51) HRH3ALDH1A1POLBKDM4ERAB9A
SCHEMBL1849443 0.68 ALDH1A1 (0.51) HRH3ALDH1A1POLBKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
EP-2323697-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY Siemens Medical Solutions USA, Inc. (US) 2011-05-25 EP disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
WO-2010011964-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB HRH3 4453/4885ALDH1A1 1389/4885POLB 2509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.